IL328714A - אגוניסטים לרצפטור s1p1 ושימושיהם - Google Patents
אגוניסטים לרצפטור s1p1 ושימושיהםInfo
- Publication number
- IL328714A IL328714A IL328714A IL32871426A IL328714A IL 328714 A IL328714 A IL 328714A IL 328714 A IL328714 A IL 328714A IL 32871426 A IL32871426 A IL 32871426A IL 328714 A IL328714 A IL 328714A
- Authority
- IL
- Israel
- Prior art keywords
- receptor agonists
- agonists
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363606375P | 2023-12-05 | 2023-12-05 | |
| PCT/US2024/058371 WO2025122555A1 (en) | 2023-12-05 | 2024-12-04 | S1p 1 receptor agonists and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL328714A true IL328714A (he) | 2026-07-01 |
Family
ID=95980349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL328714A IL328714A (he) | 2023-12-05 | 2024-12-04 | אגוניסטים לרצפטור s1p1 ושימושיהם |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR20260113006A (he) |
| CN (1) | CN122374021A (he) |
| AU (1) | AU2024395540A1 (he) |
| IL (1) | IL328714A (he) |
| MX (1) | MX2026005526A (he) |
| WO (1) | WO2025122555A1 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007010287D1 (de) * | 2006-06-05 | 2010-12-16 | Novartis Ag | Organische verbindungen |
| UA98961C2 (uk) * | 2007-06-27 | 2012-07-10 | Астразенека Аб | Похідні піразинону та їх застосування у лікуванні легеневих захворювань |
| RU2702908C2 (ru) * | 2012-11-01 | 2019-10-14 | Инфинити Фармасьютикалз, Инк. | Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы |
| HRP20221373T1 (hr) * | 2014-03-07 | 2023-01-06 | Biocryst Pharmaceuticals, Inc. | Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi |
-
2024
- 2024-12-04 IL IL328714A patent/IL328714A/he unknown
- 2024-12-04 AU AU2024395540A patent/AU2024395540A1/en active Pending
- 2024-12-04 WO PCT/US2024/058371 patent/WO2025122555A1/en active Pending
- 2024-12-04 CN CN202480076314.1A patent/CN122374021A/zh active Pending
- 2024-12-04 KR KR1020267013922A patent/KR20260113006A/ko active Pending
-
2026
- 2026-05-06 MX MX2026005526A patent/MX2026005526A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025122555A1 (en) | 2025-06-12 |
| MX2026005526A (es) | 2026-06-01 |
| KR20260113006A (ko) | 2026-07-21 |
| AU2024395540A1 (en) | 2026-03-12 |
| CN122374021A (zh) | 2026-07-10 |